Skip to content

Cooper Companies (The) (COO) — insider trading

Health Care · NASDAQ

Cooper Companies (The) (COO) has 32 reported SEC Form 4 insider transactions in our data, including 5 open-market purchases among the most recent 32 (latest 2026-09-16).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-16 Kurzius Lawrence Erik Director Open-market purchase 10,000 $54.93 $549.3K Form 4
2026-09-14 Kurzius Lawrence Erik Director Open-market purchase 10,000 $53.92 $539.1K Form 4
2026-09-14 Rosebrough Walter M Jr Director Open-market purchase 3,000 $54.29 $162.9K Form 4
2026-09-11 Keel Paul A Director Open-market purchase 4,701 $53.18 $250.0K Form 4
2026-09-11 Rosebrough Walter M Jr Director Open-market purchase 7,000 $54.11 $378.8K Form 4
2026-07-01 Keel Paul A Director Grant / award / vesting (derivative) 2,814 — $0 Form 4
2026-04-01 Rosebrough Walter M Jr Director Option exercise / conversion (derivative) 832 — $0 Form 4
2026-04-01 Rosebrough Walter M Jr Director Option exercise / conversion 832 — $0 Form 4
2026-04-01 Kurzius Lawrence Erik Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 Kurzius Lawrence Erik Director Option exercise / conversion (derivative) 3,322 — $0 Form 4
2026-04-01 Kurzius Lawrence Erik Director Option exercise / conversion 3,322 — $0 Form 4
2026-04-01 Lucchese Cynthia L Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 Lucchese Cynthia L Director Option exercise / conversion (derivative) 3,322 — $0 Form 4
2026-04-01 Lucchese Cynthia L Director Option exercise / conversion 3,322 — $0 Form 4
2026-04-01 MADDEN TERESA S Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 MADDEN TERESA S Director Option exercise / conversion (derivative) 3,322 — $0 Form 4
2026-04-01 MADDEN TERESA S Director Option exercise / conversion 3,322 — $0 Form 4
2026-04-01 Rosebrough Walter M Jr Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 Carbone Barbara Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 Carbone Barbara Director Option exercise / conversion (derivative) 3,050 — $0 Form 4
2026-04-01 Carbone Barbara Director Option exercise / conversion 3,050 — $0 Form 4
2026-04-01 Jay Colleen Director Grant / award / vesting (derivative) 4,157 — $0 Form 4
2026-04-01 Jay Colleen Director Option exercise / conversion (derivative) 3,322 — $0 Form 4
2026-04-01 Jay Colleen Director Option exercise / conversion 3,322 — $0 Form 4
2026-04-01 Rivas Maria Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 Rivas Maria Director Option exercise / conversion (derivative) 3,322 — $0 Form 4
2026-04-01 Rivas Maria Director Option exercise / conversion 3,322 — $0 Form 4
2026-04-01 WEISS ROBERT S Director Grant / award / vesting (derivative) 3,779 — $0 Form 4
2026-04-01 WEISS ROBERT S Director Option exercise / conversion (derivative) 3,654 — $0 Form 4
2026-04-01 WEISS ROBERT S Director Option exercise / conversion 3,654 — $0 Form 4
2026-01-03 Rosebrough Walter M Jr Director Grant / award / vesting (derivative) 832 — $0 Form 4
2024-12-10 Andrews Brian G Officer (EVP, CFO & Treasurer) Grant / award / vesting (derivative) 41,563 — $0 Form 4/A

Ask the chat about COO's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Cooper Companies (The) (COO).

Last updated 2026-09-16 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.